Alliancebernstein L.P. Sells 153,401 Shares of Intuitive Surgical, Inc. $ISRG

Alliancebernstein L.P. cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,042,414 shares of the medical equipment provider’s stock after selling 153,401 shares during the quarter. Intuitive Surgical comprises 0.6% of Alliancebernstein L.P.’s portfolio, making the stock its 26th biggest holding. Alliancebernstein L.P. owned 1.13% of Intuitive Surgical worth $1,807,889,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in ISRG. Vanguard Group Inc. raised its position in shares of Intuitive Surgical by 0.8% in the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after purchasing an additional 263,828 shares during the period. State Street Corp lifted its stake in shares of Intuitive Surgical by 1.2% during the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock worth $8,451,223,000 after buying an additional 182,871 shares during the last quarter. Capital World Investors boosted its holdings in shares of Intuitive Surgical by 1.5% during the 3rd quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock worth $3,456,223,000 after buying an additional 116,034 shares during the period. Norges Bank bought a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $2,569,260,000. Finally, Invesco Ltd. grew its stake in Intuitive Surgical by 4.8% in the 2nd quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock valued at $2,402,488,000 after buying an additional 201,159 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA clearance expands da Vinci 5 into cardiac surgery, opening a much larger long-term TAM (management cites a jump from ~17k to ~160k addressable procedures in cleared markets) — a multi-year growth driver for procedure volume and consumables. Read More.
• Positive Sentiment: Completed acquisition of Southern Europe distributor businesses (Italy, Spain, Portugal) shifts da Vinci and Ion sales to direct operations — should improve control of regional sales/service and capture margin/recurring revenue over time. Read More.
• Positive Sentiment: Sell-side momentum: Citigroup upgraded ISRG to Buy and several analysts maintain bullish price targets, supporting upside thesis and sentiment. Read More.
• Positive Sentiment: Recent Q4 results beat consensus (strong revenue and EPS growth), reinforcing recurring-consumables revenue and the upgrade cycle for da Vinci systems. Read More.
• Neutral Sentiment: Analyst consensus shows meaningful upside (Zacks highlights ~29.7% average target upside), but that depends on execution and multiple expansion remaining intact. Read More.
• Neutral Sentiment: Long-form bullish pieces reiterate a multi-year growth story from da Vinci 5, Ion and software/services but don’t change near-term valuation concerns. Read More.
• Negative Sentiment: Cybersecurity incident (phishing-linked breach affecting internal systems) is the immediate catalyst for the share decline — investors will watch for customer impact, data exposure, and remediation costs. Read More.
• Negative Sentiment: Insider selling (recent EVP share sales) and management guidance calling for a deceleration in worldwide da Vinci procedure growth in 2026 could pressure near-term sentiment and valuation. Read More. • Read More.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $472.16 on Friday. The company has a market cap of $167.68 billion, a price-to-earnings ratio of 59.84, a PEG ratio of 3.64 and a beta of 1.66. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The stock has a fifty day moving average price of $513.26 and a 200-day moving average price of $512.67.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter last year, the business earned $2.21 earnings per share. Intuitive Surgical’s revenue was up 18.8% on a year-over-year basis. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In other news, SVP Mark Brosius sold 2,362 shares of the business’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the transaction, the senior vice president directly owned 3,554 shares in the company, valued at approximately $1,772,308.72. The trade was a 39.93% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gary S. Guthart sold 24,500 shares of the business’s stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the completion of the transaction, the director owned 3,694 shares of the company’s stock, valued at $1,958,189.40. The trade was a 86.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 33,407 shares of company stock valued at $17,534,067 in the last 90 days. 0.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 19th. Truist Financial boosted their price target on Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a research note on Thursday, December 18th. Evercore decreased their price objective on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a report on Friday, January 23rd. Barclays set a $712.00 price objective on Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday, January 26th. Finally, Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price for the company in a research report on Wednesday. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $615.86.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.